M1 Kliniken AG (ETR:M12)
Germany · Delayed Price · Currency is EUR 18.36
0.00 (0.00%)
Aug 26, 2026, 5:35 PM CET
M1 Kliniken AG Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 22.13 | 16.02 | 10.27 | 4.32 | 8.91 |
Depreciation & Amortization | 4.88 | 5.16 | 5.31 | 5.86 | 5.64 |
Loss (Gain) From Sale of Assets | 0.99 | 0.01 | -0.04 | 0.13 | 0.06 |
Other Operating Activities | 3.09 | 7.5 | 1.11 | 3.1 | 4.72 |
Change in Accounts Receivable | 2.84 | 13.64 | 7.29 | -4.38 | -15.54 |
Change in Inventory | 11.77 | 8.72 | -17.18 | 7.6 | 7.13 |
Change in Accounts Payable | -7.95 | -20.2 | 1.02 | 4.97 | 5.25 |
Change in Other Net Operating Assets | 0.19 | -0.3 | 0.02 | -0.82 | -0.48 |
Operating Cash Flow | 37.95 | 30.55 | 7.81 | 20.77 | 15.68 |
Operating Cash Flow Growth | 24.23% | 291.14% | -62.40% | 32.41% | 64.40% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.11 | -0.77 | -0.45 | -1.16 | -1.03 |
Sale of Property, Plant & Equipment | 0.06 | 0.01 | 0.05 | 0.07 | 0.18 |
Divestitures | - | - | - | - | 1.08 |
Sale (Purchase) of Intangibles | 0.12 | - | -0.55 | -0.61 | -0.31 |
Investment in Securities | 0.32 | -4.91 | -9.1 | -0.07 | - |
Other Investing Activities | -3.99 | - | 0.69 | 0.65 | 0.29 |
Investing Cash Flow | -3.59 | -5.67 | -9.36 | -1.12 | 0.21 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | -4.1 | -18.58 | -28.9 | -4.59 | -8.29 |
Net Debt Issued (Repaid) | -4.1 | -18.58 | -28.9 | -4.59 | -8.29 |
Issuance of Common Stock | - | 0.85 | 7.58 | - | 2.01 |
Repurchase of Common Stock | -0 | -1.88 | -3.63 | -15.55 | - |
Common Dividends Paid | -9.31 | -9.31 | -1.98 | -1.82 | -1.66 |
Other Financing Activities | -1.2 | -1.53 | -0.89 | -0.4 | 11.97 |
Financing Cash Flow | -14.61 | -30.44 | -27.82 | -22.37 | 4.03 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.06 | -0.1 | 0.07 | -0.01 | -0.01 |
Miscellaneous Cash Flow Adjustments | 2.39 | -0 | 13.01 | -0 | - |
Net Cash Flow | 22.19 | -5.66 | -16.29 | -2.72 | 19.91 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 37.84 | 29.78 | 7.35 | 19.61 | 14.66 |
Free Cash Flow Growth | 27.07% | 304.89% | -62.49% | 33.76% | 69.77% |
Free Cash Flow Margin | 10.39% | 8.78% | 2.33% | 6.87% | 4.66% |
Free Cash Flow Per Share | 2.04 | 1.60 | 0.39 | 1.07 | 0.79 |
Levered Free Cash Flow | 36.31 | 23.49 | 5.08 | 16.91 | 30.98 |
Unlevered Free Cash Flow | 37.28 | 24.69 | 5.92 | 17.43 | 31.55 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 1.2 | 1.53 | 0.89 | 0.4 | 0.51 |
Cash Income Tax Paid | 9.28 | 5.91 | 4.38 | 2.16 | 0.03 |
Change in Working Capital | 6.85 | 1.86 | -8.85 | 7.37 | -3.64 |